MARKET

ONC

ONC

BeOne Medicines Ltd.
NASDAQ
348.85
-5.07
-1.43%
After Hours: 348.99 +0.14 +0.04% 19:33 02/09 EST
OPEN
350.69
PREV CLOSE
353.92
HIGH
358.00
LOW
345.47
VOLUME
247.18K
TURNOVER
--
52 WEEK HIGH
385.22
52 WEEK LOW
196.45
MARKET CAP
38.26B
P/E (TTM)
670.35
1D
5D
1M
3M
1Y
5Y
1D
Analysts Offer Insights on Healthcare Companies: Anixa Biosciences (ANIX) and BeOne Medicines (ONC)
TipRanks · 15h ago
Is BeOne Medicines (ONC) Using InSysBio Partnership to Quietly Redefine Its R&D Risk Strategy?
Simply Wall St · 21h ago
Weekly Report: what happened at ONC last week (0202-0206)?
Weekly Report · 23h ago
BeiGene Ltd (6160) Gets a Buy from DBS
TipRanks · 1d ago
Assessing BeOne Medicines (ONC) Valuation After Analyst Support And Extended Oncology Collaboration
Simply Wall St · 3d ago
Beyond The Numbers: 6 Analysts Discuss BeOne Medicines Stock
Benzinga · 5d ago
BeOne Medicines Is Maintained at Overweight by Barclays
Dow Jones · 5d ago
BeOne Medicines Price Target Raised to $394.00/Share From $385.00 by Barclays
Dow Jones · 5d ago
More
About ONC
BeOne Medicines AG, formerly BeiGene, Ltd., is a global oncology company engaged in discovering and developing treatments for cancer patients worldwide. With a portfolio spanning hematology and solid tumors, the Company is engaged in the development of its diverse pipeline of novel therapeutics. Its products include Brukinsa, Tevimbra and Pamiparib. Brukinsa is an orally available, small-molecule inhibitor of Bruton’s tyrosine kinase (BTK). Tevimbra is a humanized immunoglobulin G4 (IgG4) anti-programmed cell death protein 1 (PD-1) monoclonal antibody with high affinity and binding specificity against PD-1. It is designed to minimize binding to Fc-gamma (Fcy) receptors on macrophages, helping the body’s immune cells detect and fight tumors. The Company’s product pipeline in development includes Sonrotoclax, Tarlatamab, Zanidatamab, Blinatumomab, BGB-26808, BGB-R046, BG-68501, BG-C9074, BGB-43395, Xaluritamig, and others.

Webull offers BeOne Medicines AG (ADR) stock information, including NASDAQ: ONC real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, ONC stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading ONC stock methods without spending real money on the virtual paper trading platform.